期刊文献+

调强适形放疗联合化疗治疗直肠癌术后复发的疗效观察 被引量:6

下载PDF
导出
摘要 直肠癌是常见的恶性肿瘤,在我国居癌症死亡第5位,手术是首选治疗方法,但单纯手术术后复发率超过40%。直肠癌术后复发应争取再次手术,若不能手术则应采取放、化疗综合治疗。既往常规放疗由于照射体积大,为减少对正常组织的放射损伤,很难用到根治剂量,疗效难以提高。随着放疗新技术的发展,如调强放射治疗(IMRT),在保证局部病灶区域高剂量的同时,又能使周围正常组织的照剂量下降。现对采用IMRT技术与常规放疗的直肠癌术后复发患者资料作一分析,报告如下。
出处 《浙江临床医学》 2014年第8期1252-1254,共3页 Zhejiang Clinical Medical Journal
  • 相关文献

参考文献15

  • 1殷蔚柏,余子豪,徐国镇,编.肿瘤放射治疗学第4版.北京:中国协和医科大学出版社.2008:855. 被引量:1
  • 2Folkesson J,Birgisson H,Pahlman L,et al. Swedish Rectal Cancer Trial :long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol,2005,23(24):5644-5650. 被引量:1
  • 3李莎,田种泽,岳养军,薛龙,朱向辉,陈小华,石万萍.术后复发直肠癌同期放化疗与单纯放疗的随机临床研究[J].中华临床医师杂志(电子版),2012,6(6):35-37. 被引量:8
  • 4高献书,李洪振.局部复发直肠癌放射治疗[J].中国实用外科杂志,2011,31(4):293-296. 被引量:4
  • 5Adkison JB,McHaffie DR,Bentzen SM,et al. Phase I trial of pelvic nodal dose escalation with hypofractionated IMRT for high-risk prostate cancer. Int J Radiat Oncol Biol Phys,2012,82(1): 184-190. 被引量:1
  • 6Arbeal L,Ramos LI,Martinez-Monge R,et al. Intensity-modulated radiation therapy vs. 3D conformal radiotherapy in locally advanced rectal cancer: dosimetric comparison and clinical implications. Radiat Oncol, 2010, 26(5): 17-24. 被引量:1
  • 7Sejin Park,Yun Sik Lee. Analysis of the prognostic effectiveness of a multivisceral resection for locally advanced colorectal. J Korean Soc Coloproctol,2011,27(1):21-26. 被引量:1
  • 8Federico B,Lucio B,Cario R,et al. Surgical treatment of local recurrent rectal carcinoma. Dis Colon Rectum,1997,40(t2):1412-1421. 被引量:1
  • 9Ballonoff A,Kavanagh B,Mc-Carter M,et al. Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase Ⅱ trial. AmJ Clin Oncol,2008,1(3):264-270. 被引量:1
  • 10Guiney MJ, Smith JG, Woromiuk V, et al. Radiotherapy treatment for isolated locoregional recurrence of rectosigmoid cancer following definitive surgery: Peter MacCallum Cancer Institute experience, 1981 - 1990. Int J Radiat Oncol Biol Phys, 1997,38, (5): 1019-1025. 被引量:1

二级参考文献24

  • 1Jian-Bin Hu,Xiao-Nan Sun,Qi-Chu Yang,Jing Xu,Qi wang,Chao He.Three-dimensional conformal radiotherapy combined with FOLFOX4 chemotherapy for unresectable recurrent rectal cancer[J].World Journal of Gastroenterology,2006,12(16):2610-2614. 被引量:12
  • 2Temple WJ, Saettler EB. Locally recrrent rectal cancer: role of composite resection of extensive pelvic tumors with strategies for minimizing risk of recurrence [J]. J Surg Oncol,2000,73(1): 47-58. 被引量:1
  • 3Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total rnesorectal excision for resee|able rectal cancer[J]. N Engl J Med, 2001,345(9):638-646. 被引量:1
  • 4Martling AL, Holm T, Rutqvist LE, et al. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project [J]. Lancet, 2000, 356 (9244):93-96. 被引量:1
  • 5Colorectal Cancer Collaborative Group Adjuvant radiotherapy for rectal cancer: A systematic overview of 8,507 patients from 22 randomised trials[J]. Lancet, 2001, 358(9290):1291. 被引量:1
  • 6Wolmark N, Wieand HS, Hyams DM, et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiother apy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02[J]. J Natl Cancer Inst, 2000, 92(5):388. 被引量:1
  • 7Gerard JP,Conroy T, Bonnetain F, et al. Preoperative radiothera py with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers:results of FFCD 9203 [J].J Clin Oncol, 2006, 24(28):4620-4625. 被引量:1
  • 8Bosset JF, Collette L, Calais G, et al. Chemotherapy with preop erative radiotherapy in rectal cancer[J]. N Engl J Med, 2006, 355(11):1114-1123. 被引量:1
  • 9Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer[J]. N Engl J Med, 2004, 351(17):1731. 被引量:1
  • 10Frykhohn GJ ,Pahlman L, Glimelius B. Combied chemoand ra diotherapy vs. radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum [J]. Int J Radiat Oncol Biol Phys, 2001,50(2):427-434. 被引量:1

共引文献14

同被引文献40

  • 1宋永文,钱立庭,李晔雄,刘新帆,金晶,王维虎,刘跃平,王淑莲.直肠癌的预后因素和治疗失败原因分析[J].中国肿瘤,2006,15(7):484-487. 被引量:6
  • 2Chan CC, Fan CW, KuoYB, et al. Multiple serological biomarkers for colorectal cancer detection [ J ]. Int J Cancer, 2009,126 (7) : 1683-1690. 被引量:1
  • 3Park S, Lee YS. Analysis of the prognostic efectiveness of amultivis- ceral resection for locally advanced colorectal [ J ]. J Korean Soc C oloproctol,2011,27( 1 ) :21-26. 被引量:1
  • 4Adkison JB, McHaffie DR, Bentzen SM, et al. Phase I trial of pelvic noda 1 dose escalation with hypofractionated IMRT for high-risk prostate cancer [ J ]. Int J Radiat Oncol Biol Phys, 2012,82 ( 1 ) : 184-190. 被引量:1
  • 5Arbeal L, Ramos LI, Martinez-Monge R, et al. Intensity-modulated radiation therapy Vs. 3D conformal radiotherapy in locally advanced rectal cancer: dosimetric comparison and clinical implications [ J ]. Radiat Oncol,2010,26(5) :17-24. 被引量:1
  • 6Koizumi W, Takiuchi H, Yamada Y, et al. Phase II study of oxalipla- tin plus S-1 as first-line treatment for advanced gastric cancer( G- SOX study) [ J]. Ann Oncol,2010,21 (5) :1001-1005. 被引量:1
  • 7Emi M, Yamaguchi Y, Hihara J, et al. Phase I trial of oxaliplatin plus S-1 chemotherapy in patients with metastatic coloectal cancer [ J]. Oneol lett,2010,1 ( 1 ) :95-98. 被引量:1
  • 8Muro K, Boku N, Shimada Y, et al. Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus imotecan ( FOLFIRI ) as second- line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study ( FIRIS study ) [ J ]. Lancet Oneol, 2010.11 f9) :853-860. 被引量:1
  • 9邹卉瑜,陈笑艳,张逸凡,刘可,钟大放.替吉奥胶囊(S-1)在中国癌症患者体内的药代动力学和生物等效性[J].中国临床药理学杂志,2010,26(5):349-354. 被引量:37
  • 10高献书,李洪振.局部复发直肠癌放射治疗[J].中国实用外科杂志,2011,31(4):293-296. 被引量:4

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部